Atea Pharmaceuticals Inc. (AVIR): Price and Financial Metrics
AVIR Price/Volume Stats
Current price | $3.38 | 52-week high | $4.14 |
Prev. close | $3.32 | 52-week low | $2.45 |
Day low | $3.33 | Volume | 515,900 |
Day high | $3.45 | Avg. volume | 386,235 |
50-day MA | $2.97 | Dividend yield | N/A |
200-day MA | $3.18 | Market Cap | 289.26M |
AVIR Stock Price Chart Interactive Chart >
Atea Pharmaceuticals Inc. (AVIR) Company Bio
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
AVIR Price Returns
1-mo | 16.55% |
3-mo | 6.29% |
6-mo | 2.74% |
1-year | -3.15% |
3-year | -52.59% |
5-year | N/A |
YTD | 0.90% |
2024 | 9.84% |
2023 | -36.59% |
2022 | -46.20% |
2021 | -78.60% |
2020 | N/A |
Loading social stream, please wait...